The medicine price of traditional Chinese medicine remains high Catch up with and surpass the gold

The medicine price of traditional Chinese medicine remains high Catch up with and surpass the gold
A kilogram of Cordyceps is fried to 200,000. At present, are being fried high Chinese medicinal materials " personal value " constantly Catching up with and surpassing the gold. Meanwhile, the entreprise cost of pharmacy taking Chinese medicinal materials as raw materials is increasing constantly, the profit has become thin gradually. In the near future, some pharmacy enterprises say one after another, if the raw materials medicine price continues rising, they apply, raise medicines, call for bid price to national development and reform committee. This scene had appeared two years ago, some traditional Chinese medicine material prices such as six flavor digitalis pills, sweet potatoes presented rise at that time, some pharmacy enterprises put forward to national development and reform committee and raise the price of medicines, this requirement has been satisfied. But with a different two years ago one, the upward kind of this Chinese medicinal materials was up to 30 kinds. The insider estimates and examines, more Chinese medicinal materials rise in price in the second half year or next year. Compound medicines and pure Chinese medicine that and develop Chinese herbal medicine, the sales volume of 2009 accounts for half of the sales volume of all medicines. This time, accept the requirement that the medicine enterprise raises the price again, it will be a thorny problem in front of national development and reform committee. Because the original intention that this and national basic medicine system just issued force down the medicine price runs counter to. Crude drugs are expensive since March of this year first type influenza in gold, Chinese medicinal materials which regard blue root of the board as the bellwether pull open the upward prelude. The medicine price remains high. By May 26, the purchasing price of the blue root of the board has already been up to 28 yuan per kilogram, and the purchasing price at the same period last year is between 6 yuan in 5 yuan per kilogram. Each red price that spend about 100 yuans from last year already too, the hurricane rose to present 635 yuan per kilogram. In the crude drugs kind of surging price, will be belonged to Radix Notoginseng and grass in spring and summer of winter by the dispute fully. As far as reporter know, during January of this year, price of per kilogram of Radix Notoginseng is only 295 yuan, improve to 585 yuan at present. And per kilogram of Cordyceps, the seller costs 200,000. "Now, Chinese medicinal materials are even more costly than the gold. " The manager of a pharmacy of the Inner Mongol says with feeling. China's largest Chinese medicinal materials information and open network of sales platform medicine, have made 100 kinds of commonly used crude drugs into the price index, after falling after rise at Radix Notoginseng, price of seed of boat-fruited sterculia, but this index broke through 5000 pieces of high point recently at early May. It is reported safflower, root of herbaceous peony, Radix Platycodonis, amomum, cloud wood fragrant and root bark of tree peony, the intersection of Zhejiang and shellfish, Rhizoma Seu Radix Notopterygii, the intersection of water and the intersection of tuber of pinellia, Matrimony vine,etc. and medicines have different rise of range, among them, the price of crude drugs such as Radix Platycodonis, safflower, amomum, Rhizoma Seu Radix Notopterygii,etc. has risen more than one time than the end of last year. Analyze, this price rises by a wide margin, own the treble factor in common according to the insider. It is a reason of the natural calamity at first, Yunnan is the main producing region of Chinese medicinal materials Radix Notoginseng, but the great drought of this year, lead to the fact the output of Radix Notoginseng drops by a wide margin. Secondly it is that wild Chinese herbal medicine is in the increasingly few state at present, in addition the related departments issue the industrial policy and exercise restraint in gathering in a large amount, this makes Chinese medicinal materials have a reason to rise in price - -Wild herbal nature cultivates 10 times of Chinese herbal medicine to draws the liquid. Finally, some people's evil intention was cornered, made profit, brought up Chinese medicinal materials " personal value " Catch up with and surpass the reality of the gold. "It is a trend not fought for that wild Chinese herbal medicines are fewer and fewer, add the adjustment of the industrial policy, Chinese medicinal materials rise in price, I'm afraid it is a trend in the future. " The person in charge of Lantai medicine company of the Inner Mongol thinks, perhaps it is very difficult to fall after rise at the herbal price in the future. In fact, the medicine taking Chinese medicinal materials such as Radix Notoginseng, blue root of the board, safflower, Sichuan bulb of fritillary as principal ingredients, generally used in vascular disease field of the heart brain, this kind of disease is common disease. The above-mentioned several kinds of Chinese medicinal materials are often used for developing daily type medicines of clearing away heat, having fire, detoxifying etc. too. And according to the estimation by insider, compound medicines and pure Chinese medicine that develop Chinese herbal medicine, the sales volume of 2009 accounts for half of the sales volume of all medicines. So agitation of rising in price, together, drugmaker including that supply upstream crude drugs to downstream medicines, retail pay close attention to the fact rather. Pinch, down March Chinese medicinal materials began to rise in price since, the general manager of medicine company group square people already turned on several meetings in the company this morning while being double, determine finally, reduce the amount of production. Generally speaking, when pharmacy enterprises confirm the materials procurement agreement with the supplier in the very beginning at the end of one, will adopt the pricing way of quarter in order to evade the risk of fluctuating of prices, but this kind of agreement has certain upper and lower limits on ups and downs of the price, exceed the purchase price that this limit will adopt and fluctuate according to market conditions automatically. And a that medicine company produce lower fire Chinese medicine while being taking board blue root,etc. as principal ingredients this morning, it is 1 point 6 mao to offer the commodity price when last year, the retail price was 2 point 7 mao. At present, offer the commodity price to already rise 2 point 6 mao, highest 4 mao of retail price. "Can only break even and does not sustain economic losses either like this. " Fang GuoMin says, produced more than 50 million bags last year, in cases the situation is not clear at present, can only guard and advance, compare and totally withdraw from the market, dropping in production can keep the cognition degree of the market at least. And for relevant person in charge of Lantai medicine company of the Inner Mongol, the present situation of rising in price would not go so far as to let him move the plan dropping in production. The benefit kidney particle, one of the main profit medicines of this company, a section of medical insurance uses medicine, though the profit is thinner, the sales volume is large can make money equally. This medicines occupy the market share of more than 40% of the Inner Mongol at present. How long but the advantages of the small profits and quick turnover can keep on earth, this person in charge can not say OKly, especially to Chinese medicine and medicines of interpolation Chinese medicinal materials which enters the medical insurance catalogue, because of the pressure in the face of the national basic medicine system, the up space of price is not big. Under the pushing doubly of price and downstream medicines retail price of upstream raw materials, most Chinese medicine pharmacy enterprises say, will type the report and apply to price to the development and reform committee again, raise the price of medicines. Once this kind of motion embarks on journey, under the drawing high of the price, the medicines gross sales amount in 2010 will be well-above 2009. But under the circumstances that the national basic medicine system has just implemented the situation in less than one year, such price rising is obviously a little unseasonable in application.

|